US Stock MarketDetailed Quotes

ENSC Ensysce Biosciences

Watchlist
  • 0.4939
  • -0.0073-1.46%
Close Nov 29 13:00 ET
  • 0.5200
  • +0.0261+5.28%
Post 16:55 ET
9.67MMarket Cap-254P/E (TTM)

Ensysce Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.91%-1.02M
25.69%-2.31M
5.50%-3.41M
39.73%-10.78M
45.33%-1.8M
66.30%-2.26M
30.00%-3.11M
-4.94%-3.61M
-117.02%-17.89M
12.53%-3.3M
Net income from continuing operations
124.59%661.77K
12.12%-1.97M
-42.19%-3.12M
56.10%-10.63M
36.03%-3.5M
72.70%-2.69M
71.74%-2.24M
-130.49%-2.19M
16.94%-24.21M
45.42%-5.48M
Operating gains losses
62.83%-6.4K
82.08%-7.82K
95.91%-8.96K
95.78%-283.96K
99.92%-4.09K
-101.63%-17.22K
70.60%-43.62K
92.17%-219.03K
-145.65%-6.74M
-240.02%-4.84M
Other non cash items
-46.58%4.06K
62,747.73%27.57K
926.56%1.2M
-95.84%344.65K
-91.76%482.12K
-99.70%7.6K
-100.00%-44
86.18%-145.03K
13.13%8.29M
27.84%5.85M
Change In working capital
-545.05%-1.7M
56.99%-388.39K
-29.67%-1.51M
-117.28%-947.08K
-73.01%742K
167.25%382.11K
-138.58%-902.99K
-221.69%-1.17M
520.55%5.48M
254.36%2.75M
-Change in receivables
-974,013.75%-1.56M
-170.43%-128K
110.70%1.34K
8.71%179.26K
107.48%10.18K
-100.12%-160
-65.84%181.73K
96.60%-12.49K
137.33%164.9K
61.67%-136.01K
-Change in prepaid assets
-350.72%-1.92M
22.40%277.61K
-135.74%-86.7K
-15.77%1.39M
-86.67%156.93K
20.80%765.85K
130.64%226.81K
-58.31%242.59K
202.27%1.65M
226.24%1.18M
-Change in payables and accrued expense
563.57%1.78M
58.98%-538K
-2.23%-1.43M
-168.73%-2.52M
-66.35%574.89K
71.33%-383.58K
-151.46%-1.31M
-287.70%-1.4M
385.80%3.66M
445.84%1.71M
Cash from discontinued investing activities
Operating cash flow
54.91%-1.02M
25.69%-2.31M
5.50%-3.41M
39.73%-10.78M
45.33%-1.8M
66.30%-2.26M
30.00%-3.11M
-4.94%-3.61M
-117.02%-17.89M
12.53%-3.3M
Investing cash flow
Cash flow from continuing investing activities
0
4.5K
0
Net other investing changes
----
----
----
----
----
----
----
----
--4.5K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
--4.5K
--0
Financing cash flow
Cash flow from continuing financing activities
4,131.70%4.13M
-100.93%-51.23K
203.42%5.69M
-0.11%8.76M
-24.70%1.46M
-101.37%-102.46K
2,177.51%5.52M
579.20%1.87M
-56.85%8.77M
-78.88%1.94M
Net issuance payments of debt
--0
--0
-16.81%-485.19K
-90.12%605.43K
240.53%1.61M
--0
-120.03%-584.86K
---415.35K
-55.97%6.13M
-112.05%-1.14M
Net common stock issuance
--1.67M
--0
--0
139.21%9.05M
--0
--0
--6.36M
--2.69M
-42.91%3.78M
--3.78M
Proceeds from stock option exercised by employees
--3.85M
--0
--6.33M
----
----
--0
--0
--0
----
----
Net other financing activities
-1,257.15%-1.39M
79.82%-51.23K
61.46%-153.68K
21.29%-899.55K
79.37%-144.54K
-100.23%-102.46K
---253.84K
-1.90%-398.72K
-133.94%-1.14M
-138.96%-700.45K
Cash from discontinued financing activities
Financing cash flow
4,131.70%4.13M
-100.93%-51.23K
203.42%5.69M
-0.11%8.76M
-24.70%1.46M
-101.37%-102.46K
2,177.51%5.52M
579.20%1.87M
-56.85%8.77M
-78.88%1.94M
Net cash flow
Beginning cash position
-72.76%1.04M
140.46%3.4M
-64.30%1.12M
-74.34%3.15M
-67.48%1.46M
2.54%3.83M
-83.23%1.42M
-74.34%3.15M
6,215.06%12.26M
-34.22%4.5M
Current changes in cash
231.51%3.11M
-197.82%-2.36M
231.69%2.28M
77.80%-2.02M
74.86%-340.78K
-407.78%-2.37M
151.29%2.41M
54.71%-1.73M
-175.53%-9.12M
-125.01%-1.36M
End cash Position
183.64%4.15M
-72.76%1.04M
140.46%3.4M
-64.30%1.12M
-64.30%1.12M
-67.48%1.46M
2.54%3.83M
-83.23%1.42M
-74.34%3.15M
-74.34%3.15M
Free cash flow
54.91%-1.02M
25.69%-2.31M
5.50%-3.41M
39.73%-10.78M
45.33%-1.8M
66.30%-2.26M
30.00%-3.11M
-4.94%-3.61M
-117.02%-17.89M
12.53%-3.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.91%-1.02M25.69%-2.31M5.50%-3.41M39.73%-10.78M45.33%-1.8M66.30%-2.26M30.00%-3.11M-4.94%-3.61M-117.02%-17.89M12.53%-3.3M
Net income from continuing operations 124.59%661.77K12.12%-1.97M-42.19%-3.12M56.10%-10.63M36.03%-3.5M72.70%-2.69M71.74%-2.24M-130.49%-2.19M16.94%-24.21M45.42%-5.48M
Operating gains losses 62.83%-6.4K82.08%-7.82K95.91%-8.96K95.78%-283.96K99.92%-4.09K-101.63%-17.22K70.60%-43.62K92.17%-219.03K-145.65%-6.74M-240.02%-4.84M
Other non cash items -46.58%4.06K62,747.73%27.57K926.56%1.2M-95.84%344.65K-91.76%482.12K-99.70%7.6K-100.00%-4486.18%-145.03K13.13%8.29M27.84%5.85M
Change In working capital -545.05%-1.7M56.99%-388.39K-29.67%-1.51M-117.28%-947.08K-73.01%742K167.25%382.11K-138.58%-902.99K-221.69%-1.17M520.55%5.48M254.36%2.75M
-Change in receivables -974,013.75%-1.56M-170.43%-128K110.70%1.34K8.71%179.26K107.48%10.18K-100.12%-160-65.84%181.73K96.60%-12.49K137.33%164.9K61.67%-136.01K
-Change in prepaid assets -350.72%-1.92M22.40%277.61K-135.74%-86.7K-15.77%1.39M-86.67%156.93K20.80%765.85K130.64%226.81K-58.31%242.59K202.27%1.65M226.24%1.18M
-Change in payables and accrued expense 563.57%1.78M58.98%-538K-2.23%-1.43M-168.73%-2.52M-66.35%574.89K71.33%-383.58K-151.46%-1.31M-287.70%-1.4M385.80%3.66M445.84%1.71M
Cash from discontinued investing activities
Operating cash flow 54.91%-1.02M25.69%-2.31M5.50%-3.41M39.73%-10.78M45.33%-1.8M66.30%-2.26M30.00%-3.11M-4.94%-3.61M-117.02%-17.89M12.53%-3.3M
Investing cash flow
Cash flow from continuing investing activities 04.5K0
Net other investing changes ----------------------------------4.5K--0
Cash from discontinued investing activities
Investing cash flow --------------0------------------4.5K--0
Financing cash flow
Cash flow from continuing financing activities 4,131.70%4.13M-100.93%-51.23K203.42%5.69M-0.11%8.76M-24.70%1.46M-101.37%-102.46K2,177.51%5.52M579.20%1.87M-56.85%8.77M-78.88%1.94M
Net issuance payments of debt --0--0-16.81%-485.19K-90.12%605.43K240.53%1.61M--0-120.03%-584.86K---415.35K-55.97%6.13M-112.05%-1.14M
Net common stock issuance --1.67M--0--0139.21%9.05M--0--0--6.36M--2.69M-42.91%3.78M--3.78M
Proceeds from stock option exercised by employees --3.85M--0--6.33M----------0--0--0--------
Net other financing activities -1,257.15%-1.39M79.82%-51.23K61.46%-153.68K21.29%-899.55K79.37%-144.54K-100.23%-102.46K---253.84K-1.90%-398.72K-133.94%-1.14M-138.96%-700.45K
Cash from discontinued financing activities
Financing cash flow 4,131.70%4.13M-100.93%-51.23K203.42%5.69M-0.11%8.76M-24.70%1.46M-101.37%-102.46K2,177.51%5.52M579.20%1.87M-56.85%8.77M-78.88%1.94M
Net cash flow
Beginning cash position -72.76%1.04M140.46%3.4M-64.30%1.12M-74.34%3.15M-67.48%1.46M2.54%3.83M-83.23%1.42M-74.34%3.15M6,215.06%12.26M-34.22%4.5M
Current changes in cash 231.51%3.11M-197.82%-2.36M231.69%2.28M77.80%-2.02M74.86%-340.78K-407.78%-2.37M151.29%2.41M54.71%-1.73M-175.53%-9.12M-125.01%-1.36M
End cash Position 183.64%4.15M-72.76%1.04M140.46%3.4M-64.30%1.12M-64.30%1.12M-67.48%1.46M2.54%3.83M-83.23%1.42M-74.34%3.15M-74.34%3.15M
Free cash flow 54.91%-1.02M25.69%-2.31M5.50%-3.41M39.73%-10.78M45.33%-1.8M66.30%-2.26M30.00%-3.11M-4.94%-3.61M-117.02%-17.89M12.53%-3.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data